Search - tctmd.com

Displaying 61 - 80 of 251

Sort: Relevancy | Date

News Conference News LINC 2020

Lutonix BTK Studies: Below-the-Knee Challenges Linger

L.A. McKeown

January 29, 2020

Podcast Heart Sounds

FDA’s First Take on New Paclitaxel Concerns in CLI

Caitlin E. Cox

January 24, 2020

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

L.A. McKeown

January 15, 2020

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

Presentation TCT 2019

Emergent Drugs and Local Drug Delivery Systems

Presenter: Juan Granada

September 28, 2019

Presentation TCT 2019

Atherectomy, Balloons, and Stents: Data Update

Presenter: Eric Secemsky

September 28, 2019

Presentation TCT 2019

The BTK Interventional Toolbox: Wires and Crossing Devices

Presenter: Ehrin Armstrong

September 28, 2019

Presentation TCT 2019

Understanding BTK Disease: Impact of Lesion Type, Severity, and Location on Technique and Device Selection

Presenter: Sahil Parikh

September 28, 2019

Presentation TCT 2019

Introduction and Session Objectives

Presenter: Sahil Parikh

September 28, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Presentation TCT 2019

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

12-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Arteries Below the Knee

Presenter: Sahil Parikh

September 27, 2019

Presentation TCT 2019

Below Knee Debulking Options: Case Examples of When I Wish I Had and Hadn't Used it

Presenter: Robert Beasley

September 25, 2019

Presentation TCT 2019

TCT 59: Atherosclerotic Swine Model for Anatomically Correct Investigation of Below-the-Knee Interventional Therapies: Preliminary Characterization

Presenter: Marco Ferrone

September 25, 2019

News Industry News

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

August 13, 2019

News Daily News

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

Caitlin E. Cox

August 12, 2019

Advertisement

Lutonix BTK Studies: Below-the-Knee Challenges Linger

Top Stories in Cardiology: January 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

FDA Gives Rivaroxaban Another VTE-Related Indication

Emergent Drugs and Local Drug Delivery Systems

Atherectomy, Balloons, and Stents: Data Update

The BTK Interventional Toolbox: Wires and Crossing Devices

Understanding BTK Disease: Impact of Lesion Type, Severity, and Location on Technique and Device Selection

Introduction and Session Objectives

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

12-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Arteries Below the Knee

Below Knee Debulking Options: Case Examples of When I Wish I Had and Hadn't Used it

TCT 59: Atherosclerotic Swine Model for Anatomically Correct Investigation of Below-the-Knee Interventional Therapies: Preliminary Characterization

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content